Lantheus Medical Imaging
Clinical trials sponsored by Lantheus Medical Imaging, explained in plain language.
-
New scan aims to spot hidden prostate cancer spread
Diagnosis OngoingThis study is testing whether a PYLARIFY PET scan can safely and accurately detect if prostate cancer has spread beyond the prostate gland in men with a specific, favorable intermediate-risk diagnosis. Participants receive one injection and scan, and those with suspicious results…
Phase: PHASE4 • Sponsor: Lantheus Medical Imaging • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
New scan aims to spot spreading kidney cancer
Diagnosis TerminatedThis study aimed to test a new type of imaging scan (piflufolastat F 18 PET/CT) to see if it could accurately find cancer that had spread from the kidney. It planned to enroll adults with clear cell kidney cancer who were suspected of having or were at high risk for the cancer sp…
Phase: PHASE2, PHASE3 • Sponsor: Lantheus Medical Imaging • Aim: Diagnosis
Last updated Mar 19, 2026 14:56 UTC